Finance

Lists
524731:BOM
Jenburkt Pharmaceuticals Ltd
916,05 INR
+0,01%
(+0,050) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524731...
Open
942,00 INR
High
952,45 INR
Low
916,05 INR
Mkt. cap
4,71 მლრდ.
Avg. vol.
463,00
Volume
243,00
P/E ratio
12,31
52-wk high
1 321,00 INR
52-wk low
880,10 INR
EPS
74,40 INR
Shares outstanding
4,59 მლნ.
No. of employees
801
Open
942,00 INR
High
952,45 INR
Low
916,05 INR
Mkt. cap
4,71 მლრდ.
Avg. vol.
463,00
Volume
243,00
P/E ratio
12,31
52-wk high
1 321,00 INR
52-wk low
880,10 INR
EPS
74,40 INR
Shares outstanding
4,59 მლნ.
No. of employees
801
News stories
From web sources and news partners
About Jenburkt Pharmaceuticals Ltd
CEO-
Employees801
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitejenburkt.com
Last report
6 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
355,12 მლნ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
455,58 მლნ.
430,24 მლნ.
446,32 მლნ.
355,12 მლნ.
Cost of goods sold
83,56 მლნ.
87,89 მლნ.
101,21 მლნ.
63,22 მლნ.
Cost of revenue
83,56 მლნ.
87,89 მლნ.
101,21 მლნ.
63,22 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
139,32 მლნ.
147,14 მლნ.
95,15 მლნ.
130,25 მლნ.
Operating expense
248,41 მლნ.
276,38 მლნ.
191,98 მლნ.
238,04 მლნ.
Total operating expenses
331,97 მლნ.
364,27 მლნ.
293,19 მლნ.
301,26 მლნ.
Operating income
123,60 მლნ.
65,97 მლნ.
153,13 მლნ.
53,86 მლნ.
Other non operating income
20,79 მლნ.
18,15 მლნ.
-60,40 მლნ.
15,13 მლნ.
EBT including unusual items
143,32 მლნ.
82,97 მლნ.
137,08 მლნ.
67,69 მლნ.
EBT excluding unusual items
143,32 მლნ.
82,97 მლნ.
171,23 მლნ.
67,69 მლნ.
Income tax expense
41,69 მლნ.
23,65 მლნ.
28,59 მლნ.
8,84 მლნ.
Effective tax rate
29,09%
28,51%
20,85%
13,05%
Other operating expenses
101,64 მლნ.
120,92 მლნ.
88,74 მლნ.
101,38 მლნ.
Net income
101,63 მლნ.
59,31 მლნ.
108,49 მლნ.
58,86 მლნ.
Net profit margin
22,31%
13,79%
24,31%
16,57%
Earnings per share
-
-
-
-
Interest and investment income
-
-
57,47 მლნ.
-
Interest expense
-1,07 მლნ.
-1,16 მლნ.
-392,00 ათ.
-1,30 მლნ.
Net interest expenses
-1,07 მლნ.
-1,16 მლნ.
57,07 მლნ.
-1,30 მლნ.
Depreciation and amortization charges
7,44 მლნ.
8,32 მლნ.
8,09 მლნ.
6,41 მლნ.
EBITDA
130,94 მლნ.
71,11 მლნ.
158,72 მლნ.
59,45 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები